FLAM
HCAT icon

First Light Asset Management’s Health Catalyst HCAT Stock Holding History

First Light Asset Management’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.5M Sell
12,810,861
-67,839
-0.5% -$97.9K 1.55% 22
2026
Q1 		$16.4M Sell
12,878,700
-32,241
-0.2% -$60.6K 1.47% 23
2025
Q4 		$30.9M Sell
12,910,941
-525,279
-4% -$1.44M 2.36% 18
2025
Q3 		$38.3M Buy
13,436,220
+1,206,039
+10% +$4.13M 3.61% 7
2025
Q2 		$46.1M Buy
12,230,181
+1,793,374
+17% +$7.05M 5.98% 6
2025
Q1 		$47.3M Buy
10,436,807
+5,195,686
+99% +$27.5M 5.4% 6
2024
Q4 		$37.1M Buy
5,241,121
+944,631
+22% +$7.52M 3.55% 11
2024
Q3 		$35M Buy
4,296,490
+340,401
+9% +$2.46M 2.91% 17
2024
Q2 		$25.3M Buy
3,956,089
+3,221,408
+438% +$20.7M 2.22% 23
2024
Q1 		$5.53M Sell
734,681
-279,794
-28% -$2.55M 0.42% 44
2023
Q4 		$9.39M Sell
1,014,475
-1,915,669
-65% -$15.7M 0.76% 34
2023
Q3 		$29.7M Buy
2,930,144
+389,185
+15% +$4.65M 2.82% 15
2023
Q2 		$31.8M Buy
2,540,959
+560,642
+28% +$6.68M 2.49% 13
2023
Q1 		$23.1M Buy
1,980,317
+818,322
+70% +$10.4M 2.08% 19
2022
Q4 		$12.4M Buy
1,161,995
+12,162
+1% +$117K 1.15% 30
2022
Q3 		$11.2M Buy
1,149,833
+14,668
+1% +$194K 1.13% 28
2022
Q2 		$16.4M Buy
1,135,165
+276,432
+32% +$4.71M 1.91% 21
2022
Q1 		$22.4M Buy
858,733
+45,687
+6% +$1.3M 1.98% 16
2021
Q4 		$32.2M Buy
813,046
+18,086
+2% +$824K 2.31% 17
2021
Q3 		$39.8M Buy
794,960
+5,567
+0.7% +$304K 2.62% 14
2021
Q2 		$43.8M Sell
789,393
-207,808
-21% -$11.1M 2.63% 12
2021
Q1 		$46.6M Buy
997,201
+25,304
+3% +$1.23M 3.09% 11
2020
Q4 		$42.3M Buy
971,897
+721,144
+288% +$26.6M 3.13% 10
2020
Q3 		$9.18M Buy
250,753
+352
+0.1% +$12K 0.94% 32
2020
Q2 		$7.3M Buy
250,401
+239,301
+2,156% +$6.61M 0.85% 36
2020
Q1 		$290K Hold
11,100
– – 0.05% 57
2019
Q4 		$385K Hold
11,100
– – 0.05% 53
2019
Q3 		$351K Buy
+11,100
New +$437K 0.05% 58

Other funds holding HCAT

CF
CDC Financial Chicago, Illinois $239M AUM
PVM
Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HWM
HighMark Wealth Management St. Paul, Minnesota $299M AUM 53.01% 1-Year Est. Return

First Light Asset Management's HCAT Position: Q2 2026 in Review

First Light Asset Management reduced its Health Catalyst (HCAT) stake by 0.53% in Q2 2026, selling an estimated $97.9K and leaving 12,810,861 shares worth $25.5M. The position accounts for 1.55% of the portfolio, ranked #22.

First Light Asset Management first reported a position in HCAT in Q3 2019 and has held it in 28 quarters since. The position peaked at $47.3M in Q1 2025. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • First Light Asset Management held 12,810,861 shares of Health Catalyst worth $25.5M as of Q2 2026.
  • First Light Asset Management sold 67,839 Health Catalyst shares in Q2 2026, an estimated $97.9K.
  • Health Catalyst made up 1.55% of First Light Asset Management's portfolio in Q2 2026, its #22 holding.
  • First Light Asset Management first reported a position in Health Catalyst in Q3 2019 and has held it in 28 quarters since.
  • First Light Asset Management's Health Catalyst position peaked at $47.3M in Q1 2025.
  • 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on First Light Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.